FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

RISPERDAL related Press Releases

Par Pharmaceutical Begins Shipment of Generic Risperdal(R) M-TAB

Posted June 2, 2009

Par Pharmaceutical Begins Shipment of Generic Risperdal M-TAB WOODCLIFF LAKE, N.J., June 2 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: PRX) today announced that it began... Read more...

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder

Posted February 10, 2009

FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder TITUSVILLE, N.J., Feb. 10 /PRNewswire-FirstCall/ -- Johnson & Johnson... Read more...

Ortho-McNeil-Janssen Pharmaceuticals, Inc. Release: FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia

Posted October 10, 2008

Ortho-McNeil-Janssen Pharmaceuticals, Inc. Release: FDA Approves New Injection Site for RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment TITUSVILLE, N.J., Oct. 9 /PRNewswire-FirstCall/ -- Patients... Read more...

FDA Issues Approvable Letter for RISPERDAL® to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Ma

Posted August 27, 2008

FDA Issues Approvable Letter for RISPERDAL® to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania Titusville, NJ. June 21, 2007 - Johnson & Johnson... Read more...

PRESS RELEASE: FDA Approves RISPERDAL to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania

Posted August 23, 2007

FDA Approves RISPERDAL(R) to Treat Adolescents with Schizophrenia and Children and Adolescents with Bipolar Mania TITUSVILLE, N.J., Aug. 22 -- The U.S. Food and Drug Administration... Read more...